Find clinical trials for Ovarian Cancer in Rochester, MN
CTV is a public benefit provided by Veeva Systems to help you find the most relevant clinical trials for you and your loved ones
Related conditions:
Ovarian Cancer trials near Rochester, MN, USA:
Olaparib Monotherapy in Patients with BRCA Mutated Ovarian Cancer following First Line Platinum Based Chemotherapy....
Phase 3
Rochester, Minnesota, United States and 176 other locations
study drugs pembrolizumab and lenvatinib in patients with clear cell ovarian cancer.The names of the study drugs involved in this s...
Phase 2
Rochester, Minnesota, United States and 2 other locations
within each cohort-specific supplement in participants with ovarian, fallopian tube, or primary peritoneal cancer. Cohort A (single ...
Phase 1, Phase 2
Rochester, Minnesota, United States and 24 other locations
This phase II trial studies how well pembrolizumab works in treating participants with ovarian cancer that has come back after prev...
Phase 2
Rochester, Minnesota, United States and 2 other locations
in combination with Pembrolizumab, or Pembrolizumab and Pegylated Liposomal Doxorubicin in patients with platinum resistant or refractory ovarian...
Phase 1
Rochester, Minnesota, United States and 2 other locations
of REGN4018 can be given alone or with cemiplimab to patients with ovarian cancer or cancer of the uterus* The study will ...
Phase 1, Phase 2
Rochester, Minnesota, United States and 49 other locations
in patients with platinum-resistant high-grade epithelial ovarian cancer, primary peritoneal, or fallopian tube cancer, wh...
Phase 3
Rochester, Minnesota, United States and 207 other locations
The goal of this study is to test A2B694, an autologous logic-gated Tmod™ CAR T-cell product in subjects with solid tumors including colorectal cancer...
Phase 1, Phase 2
Rochester, Minnesota, United States and 8 other locations
The study evaluates the response to treatment with Ribociclib and Letrozole in patients with low grade serous cancer of the ovary, fallopian...
Phase 2
Rochester, Minnesota, United States and 26 other locations
first-in-human study will evaluate the safety, tolerability, pharmacokinetics, and antitumor activity of TORL-1-23 in patients with advanced cancer...
Phase 1
Rochester, Minnesota, United States and 3 other locations
Clinical trials
Research sites
Resources
Legal